Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LISI S.A. M&A Activity 2022

Oct 3, 2022

1484_iss_2022-10-03_670d80ff-0804-4f47-b3d1-6dca8d3bfd45.pdf

M&A Activity

Open in viewer

Opens in your device viewer

LISI MEDICAL SIGNE UN CONTRAT STRATEGIQUE DANS LE DOMAINE DES INSTRUMENTS CHIRURGICAUX

Minneapolis (Etats-Unis) – 3 octobre 2022.

LISI MEDICAL, une division du Groupe LISI, a conclu un accord long terme avec un acteur majeur du domaine de la chirurgie mini-invasive.

Ce contrat de 4 ans, valorisé plus de 170 M\$ représente un partenariat stratégique et engageant qui renforce la position de LISI MEDICAL comme leader sur ce segment de marché.

LISI MEDICAL SIGNS A STRATEGIC CONTRACT IN THE SURGICAL INSTRUMENTS FIELD


Minneapolis (USA) - October 3, 2022.

LISI MEDICAL, a division of the LISI Group, has signed a long-term agreement with a major player in the field of minimally invasive surgery.

This 4-year contract, valued at more than \$170M, represents a strategic and binding partnership that strengthens LISI MEDICAL's position as a leader in this market segment.

About the LISI Group

_____________________

www.lisi-group.com

Contact

Emmanuel Viellard | LISI CEO Phone: 03 84 57 00 77 Mail: [email protected]

LISI is a global industrial group, specializing in the manufacture of high value-added assembly solutions and components for the aerospace, automotive and medical sectors. As a partner of the world's leading players and thanks to the commitment of more than 9,500 employees in 13 countries on 4 continents, LISI innovates and invests in the research and development of tomorrow's products; to meet the needs of its clients, particularly in terms of quality, safety and performance.

The LISI Group differentiates itself by focusing on two strategic areas: innovation and operational excellence, while integrating a strong CSR culture.